Remsima 40 mg/mL concentrate for solution for infusion

  • DHPC
Company
Celltrion Healthcare Ireland Ltd.
Active Ingredient
Strength
  • 100 mg
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026

Direct Healthcare Professional Communications

  • DHPC - Remsima - new IV formulation contraindicated in HFI

    Direct Healthcare Professional Communication (DHPC)

    PDF308.35 KB

Celltrion Healthcare Ireland Ltd.

26 Arrow Building, Old Belgard Road, Tallaght, Dublin, D24 ND70

Email
Medinfoie@celltrionhc.com